ストックスクリーナーアプリを入手
2.51
7.04%
-0.19
プレマーケット:
2.48
-0.03
-1.20%
前日終値:
$2.70
開ける：
$2.7
24時間の取引高:
356.55K
Relative Volume:
0.58
時価総額：
$124.43M
収益：
$96.63M
当期純損益:
$-63.32M
株価収益率:
-1.7192
EPS:
-1.46
ネットキャッシュフロー:
$-54.55M
1週間 パフォーマンス:
-16.05%
1か月 パフォーマンス:
+1.62%
6か月 パフォーマンス:
+24.88%
1年 パフォーマンス:
-57.89%
1日の値動き範囲:
$2.505
$2.74
1週間の範囲:
$2.505
$3.075
52週間の値動き範囲:
$1.88
$6.31
Akoya Biosciences Inc Stock (AKYA) Company Profile
AKYA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AKYA
Akoya Biosciences Inc
|
2.51 | 124.43M | 96.63M | -63.32M | -54.55M | -1.46 |
|
ISRG
Intuitive Surgical Inc
|
588.50 | 209.89B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
227.21 | 68.23B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
91.65 | 45.33B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
237.18 | 34.84B | 4.93B | 1.25B | 1.38B | 8.47 |
|
WST
West Pharmaceutical Services Inc
|
330.47 | 23.97B | 2.88B | 499.60M | 321.60M | 6.74 |
Akoya Biosciences Inc Stock (AKYA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-15 | ダウングレード | Craig Hallum | Buy → Hold |
| 2024-08-06 | ダウングレード | BTIG Research | Buy → Neutral |
| 2024-08-06 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-08-06 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2024-06-21 | 開始されました | Craig Hallum | Buy |
| 2023-12-14 | 開始されました | Guggenheim | Neutral |
| 2023-07-05 | 再開されました | JP Morgan | Overweight |
| 2023-02-02 | 開始されました | UBS | Buy |
| 2022-11-03 | 開始されました | CapitalOne | Overweight |
| 2022-10-06 | 開始されました | Stephens | Overweight |
| 2022-06-22 | 開始されました | BTIG Research | Buy |
| 2022-01-06 | 再開されました | Piper Sandler | Overweight |
| 2021-05-11 | 開始されました | Canaccord Genuity | Buy |
| 2021-05-11 | 開始されました | JP Morgan | Overweight |
| 2021-05-11 | 開始されました | Morgan Stanley | Overweight |
| 2021-05-11 | 開始されました | Piper Sandler | Overweight |
すべてを表示
Akoya Biosciences Inc (AKYA) 最新ニュース
Akoya Biosciences unveils strategic product roadmap - Yahoo Finance
Akoya Biosciences Unveils Strategic Product Roadmap, Powered by the New IO60 and Upcoming Neurobiology Panels - GlobeNewswire
Revolutionary Neurobiology Panels: Akoya's New Weapon Against Brain Disease Research - StockTitan
Akoya Biosciences, Inc. (NASDAQ:AKYA) Sees Significant Increase in Short Interest - MarketBeat
Akoya Biosciences Selects Argonaut Manufacturing Services as IVD Manufacturing Partner - Business Wire
Major Breakthrough: Akoya's Advanced Diagnostic Tech Gets Manufacturing Powerhouse Backing - StockTitan
Quanterix Nears All-Stock Deal for Akoya Biosciences - MSN
Spatial Proteomics Market Report and Competitive Landscape 2025-2030, with 10X Genomics, Bruker, Fluidigm, Akoya Biosciences, PerkinElmer, Biotechne, S2 Genomics, Seven Bridges Genomics & More - Yahoo Finance
Barclays PLC Buys 30,095 Shares of Akoya Biosciences, Inc. (NASDAQ:AKYA) - Defense World
Akoya Biosciences, Inc. (NASDAQ:AKYA) Receives Consensus Rating of “Hold” from Analysts - Defense World
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Jane Street Group LLC Decreases Stock Holdings in Akoya Biosciences, Inc. (NASDAQ:AKYA) - Defense World
Akoya Biosciences (NASDAQ:AKYA) Cut to Hold at Canaccord Genuity Group - Defense World
Akoya Biosciences (NASDAQ:AKYA) Downgraded by Canaccord Genuity Group to Hold - MarketBeat
Major Player in the Spatial Biology Market Analysis by Type, - openPR
Akoya Biosciences to be acquired by Billerica research firm, create $220M business - Worcester Business Journal
Quanterix merging with Akoya to bolster biomarker portfolio - BioWorld Online
Quanterix announces acquisition of Akoya Biosciences By Investing.com - Investing.com Canada
Quanterix announces acquisition of Akoya Biosciences - Investing.com
Billerica diagnostics maker Quanterix to acquire Marlborough biotech - The Business Journals
Akoya Biosciences (NASDAQ: AKYA) Enters Merger Agreement with Quanterix Corporation - Defense World
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates SSTK, ACCD, ESSA, AKYA on Behalf of Shareholders - GlobeNewswire Inc.
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates ESSA, AKYA, CCNE, QTRX on Behalf of Shareholders - The Malaysian Reserve
$TOCKHOLDER ALERT: The M&A Class Action Firm Is Investigating the MergerACCD, QTRX, AKYA, ESSA - Markets Insider
Quanterix Agrees to Buy Life Sciences Firm Akoya Biosciences - MSN
AKOYA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc.AKYA - Business Wire
Quanterix Is Close to All-Stock Deal for Akoya Bioscience - MSN
Akoya climbs after merger deal with Quanterix - MSN
Shareholder Alert: Ademi LLP Investigates Whether Akoya Biosciences, Inc. Is Obtaining a Fair Price for Its Public Shareholders - Business Wire
AKYA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Akoya Biosciences, Inc. Is Fair to Shareholders - Business Wire
Quanterix to acquire Akoya Biosciences in an all-stock transaction - TipRanks
Akoya stock climbs after Quanterix merger deal (AKYA:NASDAQ) - Seeking Alpha
Major Player in the Spatial Proteomics Market 20252032 - openPR
Quanterix to Acquire Akoya Biosciences, Creating the First Integrated Solution for Ultra-Sensitive Detection of Blood- and Tissue-Based Protein Biomarkers - Business Wire
A Data-Based Look At Akoya Biosciences Inc (AKYA) - Stocks Register
State Street Corp Boosts Position in Akoya Biosciences, Inc. (NASDAQ:AKYA) - Defense World
Short Interest in Akoya Biosciences, Inc. (NASDAQ:AKYA) Grows By 20.7% - Defense World
Akoya Biosciences, Inc. (NASDAQ:AKYA) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Akoya Biosciences, Inc. (NASDAQ:AKYA) Given Consensus Rating of “Hold” by Analysts - Defense World
Akoya Biosciences, Inc. (NASDAQ:AKYA) Short Interest Up 20.7% in December - MarketBeat
Akoya Biosciences, Inc. (NASDAQ:AKYA) Shares Sold by HighTower Advisors LLC - Defense World
Charles Schwab Investment Management Inc. Decreases Stake in Akoya Biosciences, Inc. (NASDAQ:AKYA) - Defense World
Akoya Biosciences updates director and officer indemnification agreements By Investing.com - Investing.com Canada
Akoya Biosciences updates director and officer indemnification agreements - Investing.com India
Akoya Biosciences, Inc. (NASDAQ:AKYA) Short Interest Up 18.1% in November - Defense World
Market Cool On Akoya Biosciences, Inc.'s (NASDAQ:AKYA) Revenues Pushing Shares 29% Lower - Simply Wall St
Akoya Biosciences Inc (AKYA) 財務データ
収益
当期純利益
現金流量
EPS
10.10%
0.93%
大文字化:
|
ボリューム (24 時間):